Robert M Haws1, Aditya Joshi2, Siddharth A Shah3, Omar Alkandari4, Martin A Turman5. 1. Department of Pediatrics, Marshfield Clinic, 1000 N Oak Ave, Marshfield, WI, 54449, USA. haws.robert@marshfieldclinic.org. 2. Department of Pediatrics, Marshfield Clinic, 1000 N Oak Ave, Marshfield, WI, 54449, USA. 3. Department of Pediatrics, University of Louisville, Louisville, KY, USA. 4. Department of Pediatrics, Mubarak Al-Kabeer Hospital & Hamid Al-Essa Transplant Center, Safat, Kuwait. 5. Department of Pediatric Nephrology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
Abstract
BACKGROUND: Renal anomalies are common in patients with Bardet-Biedl syndrome (BBS), a renal cystic ciliopathy with multi-systemic features. Renal transplantation is indicated in cases of end-stage renal disease (ESRD), but transplant centers may be hesitant to perform the necessary transplant in light of the multitude of metabolic comorbidities these patients often face with the potential to complicate outcomes. METHODS: Data from the Clinical Registry Investigating BBS (CRIBBS) were used to investigate renal transplant outcomes in the largest BBS cohort described to date. RESULTS: Of the 206 patients enrolled in the CRIBBS, 21 children (10.2 %; 16 girls, 5 boys; median age 8.4 years) had been diagnosed with ESRD. Renal transplantation was performed in 18 of these individuals between 1982 and 2015, including repeat transplantation in some cases, for a total of 22 kidneys. Overall graft survival was 81.6 % at 1 year post-transplantation, 75.7 % at 5 years, 59 % at 10 years, and 49.2 % at 25 years. Patient survival was 94.4 % at 1 year post-transplantation, 87.2 % at 8 years, and 79.3 % at 25 years. CONCLUSIONS: At a median follow-up time of 97 months, relatively few complications of renal transplantation were reported in the patients of this study. However, body mass index was significantly elevated in transplanted individuals compared to non-transplanted individuals participating in CRIBBS at the most recent follow-up. Although the frequency of obesity and other manifestations of the metabolic syndrome warrant meticulous management in this high-risk population, favorable long-term outcomes suggest that renal transplantation is a viable option for patients with BBS and ESRD.
BACKGROUND:Renal anomalies are common in patients with Bardet-Biedl syndrome (BBS), a renal cystic ciliopathy with multi-systemic features. Renal transplantation is indicated in cases of end-stage renal disease (ESRD), but transplant centers may be hesitant to perform the necessary transplant in light of the multitude of metabolic comorbidities these patients often face with the potential to complicate outcomes. METHODS: Data from the Clinical Registry Investigating BBS (CRIBBS) were used to investigate renal transplant outcomes in the largest BBS cohort described to date. RESULTS: Of the 206 patients enrolled in the CRIBBS, 21 children (10.2 %; 16 girls, 5 boys; median age 8.4 years) had been diagnosed with ESRD. Renal transplantation was performed in 18 of these individuals between 1982 and 2015, including repeat transplantation in some cases, for a total of 22 kidneys. Overall graft survival was 81.6 % at 1 year post-transplantation, 75.7 % at 5 years, 59 % at 10 years, and 49.2 % at 25 years. Patient survival was 94.4 % at 1 year post-transplantation, 87.2 % at 8 years, and 79.3 % at 25 years. CONCLUSIONS: At a median follow-up time of 97 months, relatively few complications of renal transplantation were reported in the patients of this study. However, body mass index was significantly elevated in transplanted individuals compared to non-transplanted individuals participating in CRIBBS at the most recent follow-up. Although the frequency of obesity and other manifestations of the metabolic syndrome warrant meticulous management in this high-risk population, favorable long-term outcomes suggest that renal transplantation is a viable option for patients with BBS and ESRD.
Authors: Christopher J Hill; Aisling E Courtney; Christopher R Cardwell; Alexander P Maxwell; Giuseppe Lucarelli; Massimiliano Veroux; Frederico Furriel; Robert M Cannon; Ellen K Hoogeveen; Mona Doshi; Jennifer A McCaughan Journal: Nephrol Dial Transplant Date: 2015-06-04 Impact factor: 5.992
Authors: Annemarie Weissenbacher; Maximilian Jara; Hanno Ulmer; Matthias Biebl; Claudia Bösmüller; Stefan Schneeberger; Gert Mayer; Johann Pratschke; Robert Öllinger Journal: Transplantation Date: 2012-03-15 Impact factor: 4.939
Authors: Maria Pietrzak-Nowacka; Krzysztof Safranow; Elzbieta Byra; Agnieszka Bińczak-Kuleta; Andrzej Ciechanowicz; Kazimierz Ciechanowski Journal: Kidney Blood Press Res Date: 2009-11-20 Impact factor: 2.687
Authors: Thomas H Inge; Anita P Courcoulas; Todd M Jenkins; Marc P Michalsky; Michael A Helmrath; Mary L Brandt; Carroll M Harmon; Meg H Zeller; Mike K Chen; Stavra A Xanthakos; Mary Horlick; C Ralph Buncher Journal: N Engl J Med Date: 2015-11-06 Impact factor: 91.245
Authors: Jeremy Pomeroy; Anthony D Krentz; Jesse G Richardson; Richard L Berg; Jeffrey J VanWormer; Robert M Haws Journal: Pediatr Obes Date: 2020-07-22 Impact factor: 4.000
Authors: Jennifer R Meyer; Anthony D Krentz; Richard L Berg; Jesse G Richardson; Jeremy Pomeroy; Scott J Hebbring; Robert M Haws Journal: Clin Genet Date: 2022-04 Impact factor: 4.296